November 2016

Nov 30, 2016, 04:36 ET CRANBURY, N.J., Nov. 30, 2016 /PRNewswire/ — Palatin Technologies, Inc. (“Palatin”) (NYSE MKT: PTN) today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock and warrants to purchase shares of its common stock. There can be …

Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants Read More »

Nov 15, 2016, 07:30 ET CRANBURY, N.J., Nov. 15, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its first quarter ended September 30, 2016.  Recent Highlights Bremelanotide – Under development …

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on November 15, 2016 Read More »

CRANBURY, N.J., Nov. 10, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2017 operating results on Tuesday, November 15, 2016  before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November …

Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on November 15, 2016 Read More »